VeriSIM Life, a San Francisco-based startup, has created BIOiSIM, an AI-powered platform that simulates drug compound behavior in the human body by acting like a virtual laboratory. It assigns each a predictive “credit score” predicting its viability for drug development. “It’s like a FICO score for drug development,” founder and CEO Dr. Jo Varshney said.…
How VeriSIM Life’s BIOiSIM platform could reduce pharma’s reliance on animal testing
Founded in 2017, VeriSIM Life (San Francisco) has a quest to use biosimulation technology to streamline drug discovery and development. The company’s BIOiSIM virtual drug development engine helps pharma and biotech companies optimize R&D spending. The company’s founder and CEO, Dr. Jo Varshney, also wants to help reduce the need for animal testing in drug…